Search Results

You are looking at 41 - 50 of 198 items for :

  • Risk of malignancy x
Clear All
Patrick W. Owens Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Patrick W. Owens in
Google Scholar
PubMed
Close
,
Terri P. McVeigh Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland
Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom

Search for other papers by Terri P. McVeigh in
Google Scholar
PubMed
Close
,
Eoin J. Fahey Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Eoin J. Fahey in
Google Scholar
PubMed
Close
,
Marcia Bell Department of Endocrinology, Galway University Hospital, Galway, Ireland

Search for other papers by Marcia Bell in
Google Scholar
PubMed
Close
,
Denis S. Quill Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Denis S. Quill in
Google Scholar
PubMed
Close
,
Michael J. Kerin Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Michael J. Kerin in
Google Scholar
PubMed
Close
, and
Aoife J. Lowery Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Aoife J. Lowery in
Google Scholar
PubMed
Close

impairment, or sialadenitis. More significant complications include impairment of haematopoiesis and gonadal function and increased risk for second primary malignancies, both solid and haematological. A dose of 100 mCi (3.7 GBq) of radioiodine has been

Free access
Pi-Ling Chiang Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan

Search for other papers by Pi-Ling Chiang in
Google Scholar
PubMed
Close
,
Sheng-Dean Luo Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan

Search for other papers by Sheng-Dean Luo in
Google Scholar
PubMed
Close
,
Yen-Hsiang Chang Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan

Search for other papers by Yen-Hsiang Chang in
Google Scholar
PubMed
Close
,
Chen-Kai Chou Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan

Search for other papers by Chen-Kai Chou in
Google Scholar
PubMed
Close
,
Shun-Yu Chi Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Departments of Surgery, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan

Search for other papers by Shun-Yu Chi in
Google Scholar
PubMed
Close
,
Yi-Fan Chen Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan

Search for other papers by Yi-Fan Chen in
Google Scholar
PubMed
Close
, and
Wei-Che Lin Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Department of Radiology, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan
School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung City, Taiwan

Search for other papers by Wei-Che Lin in
Google Scholar
PubMed
Close

/FLUS) category, known as Bethesda category III, has been ascribed a malignancy risk of 5–15% ( 2 , 3 , 4 , 5 ). According to international guidelines, Bethesda III thyroid nodules are not considered an indication of radiofrequency ablation (RFA) ( 6 , 7

Open access
Rima Bėrontienė Clinics of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Rima Bėrontienė in
Google Scholar
PubMed
Close
,
Edita Jašinskienė Clinics of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Edita Jašinskienė in
Google Scholar
PubMed
Close
,
Rosita Kiudelienė Clinics of Pediatrics, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Rosita Kiudelienė in
Google Scholar
PubMed
Close
,
Gintaras Kuprionis Clinics of Radiology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Gintaras Kuprionis in
Google Scholar
PubMed
Close
,
Jurgita Makštienė Clinics of Pathology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Jurgita Makštienė in
Google Scholar
PubMed
Close
,
Raminta Macaitytė Clinics of Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Raminta Macaitytė in
Google Scholar
PubMed
Close
,
Dalia Marčiulionytė Institute of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Dalia Marčiulionytė in
Google Scholar
PubMed
Close
,
Lina Poškienė Clinics of Pathology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Lina Poškienė in
Google Scholar
PubMed
Close
,
Agnė Šemetaitė Clinics of Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Agnė Šemetaitė in
Google Scholar
PubMed
Close
,
Vygantas Šidlauskas Institute of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Vygantas Šidlauskas in
Google Scholar
PubMed
Close
,
Raimondas Valickas Clinics of Radiology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Raimondas Valickas in
Google Scholar
PubMed
Close
,
Rimantas Žalinkevičius Institute of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Rimantas Žalinkevičius in
Google Scholar
PubMed
Close
, and
Rasa Verkauskienė Clinics of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania
Institute of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Search for other papers by Rasa Verkauskienė in
Google Scholar
PubMed
Close

deficiency [ 9 ]. Both of these risk factors were present in Lithuania at certain time periods, i.e. the radioactive cloud after the Chernobyl accident passed over the territory, and Lithuania was considered to be a mild to moderate iodine-deficient zone up

Free access
Kristine Z Swan Department of ORL, Head- and Neck Surgery, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Kristine Z Swan in
Google Scholar
PubMed
Close
,
Johnson Thomas Department of Endocrinology, Mercy Hospital, Springfield, Missouri, USA

Search for other papers by Johnson Thomas in
Google Scholar
PubMed
Close
,
Viveque E Nielsen Department of ORL, Head- and Neck Surgery, Odense University Hospital, Odense, Denmark

Search for other papers by Viveque E Nielsen in
Google Scholar
PubMed
Close
,
Marie Louise Jespersen Department of Pathology, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Marie Louise Jespersen in
Google Scholar
PubMed
Close
, and
Steen J Bonnema Department of Endocrinology, Odense University Hospital, Odense, Denmark

Search for other papers by Steen J Bonnema in
Google Scholar
PubMed
Close

stratification of thyroid nodules, of which only few are malignant ( 3 ). Therefore, clinicians must balance the risk of overlooking malignancy while reducing the number of unnecessary biopsies in order to avoid overtreatment of benign nodules. If a biopsy is

Open access
Axel Sahovaler Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada
Guided Therapeutics (GTx) Program, Techna Institute, University Health Network, Toronto, Ontario, Canada

Search for other papers by Axel Sahovaler in
Google Scholar
PubMed
Close
,
Marco Ferrari Guided Therapeutics (GTx) Program, Techna Institute, University Health Network, Toronto, Ontario, Canada
Unit of Otorhinolaryngology – Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiologic Sciences, and Public Health, University of Brescia, Brescia, Italy
Section of Otorhinolaryngology – Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy

Search for other papers by Marco Ferrari in
Google Scholar
PubMed
Close
,
Jonathan Athayde Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada

Search for other papers by Jonathan Athayde in
Google Scholar
PubMed
Close
,
Adrian Mendez Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada

Search for other papers by Adrian Mendez in
Google Scholar
PubMed
Close
,
Kevin Fung Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada

Search for other papers by Kevin Fung in
Google Scholar
PubMed
Close
,
John Yoo Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada

Search for other papers by John Yoo in
Google Scholar
PubMed
Close
,
Anthony C. Nichols Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada

Search for other papers by Anthony C. Nichols in
Google Scholar
PubMed
Close
, and
S. Danielle MacNeil Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada

Search for other papers by S. Danielle MacNeil in
Google Scholar
PubMed
Close

Dear Editor, The recently published “Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer” (WDTC) by Chan et al. [ 1 ] aimed to focus on tumors between 1 and 4 cm, which represent the

Free access
Pedro Weslley Souza Rosario Santa Casa de Belo Horizonte, Belo Horizonte, Brazil

Search for other papers by Pedro Weslley Souza Rosario in
Google Scholar
PubMed
Close

. References 1 Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L: European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: The EU-TIRADS. Eur Thyroid J 2017; 6: 225–237. 10

Free access
Johannes Järhult Department of Surgery, Highland Hospital, Eksjö, Sweden
Department of Surgery, County Hospital Ryhov, Jönköping, Sweden

Search for other papers by Johannes Järhult in
Google Scholar
PubMed
Close
and
Ramtin Vedad Department of Surgery, County Hospital Ryhov, Jönköping, Sweden

Search for other papers by Ramtin Vedad in
Google Scholar
PubMed
Close

, Sugawara M: Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 1994;18:495-499. 10.1007/BF00353745 7725734 20 Rios A, Rodriguez JM, Canteras M, Galindo PJ, Balsalobre MD, Parrilla P: Risk factors for malignancy in

Free access
Mathieu Spaas Department of Radiation Oncology, KU Leuven – University of Leuven, University Hospitals Leuven, Leuven, Belgium

Search for other papers by Mathieu Spaas in
Google Scholar
PubMed
Close
,
Brigitte Decallonne Department of Endocrinology and Internal Medicine, KU Leuven – University of Leuven, University Hospitals Leuven, Leuven, Belgium

Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Close
,
Annouschka Laenen Leuven Biostatistics and Statistical Bioinformatics Centre, Leuven, Belgium

Search for other papers by Annouschka Laenen in
Google Scholar
PubMed
Close
,
Jaak Billen Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium

Search for other papers by Jaak Billen in
Google Scholar
PubMed
Close
, and
Sandra Nuyts Department of Radiation Oncology, KU Leuven – University of Leuven, University Hospitals Leuven, Leuven, Belgium

Search for other papers by Sandra Nuyts in
Google Scholar
PubMed
Close

account biochemical disease recurrence or persistence without structural evidence of malignancy. As research into improving prognostication in DTC patients continues, the ATA has recently introduced the concept of dynamic risk stratification. Furthermore

Free access
Rachelle P Mendoza Department of Pathology, University of Rochester Medical Center, Rochester, New York, USA

Search for other papers by Rachelle P Mendoza in
Google Scholar
PubMed
Close
,
Richard Cody Simon Department of Pathology, University of Chicago, Chicago, Illinois, USA

Search for other papers by Richard Cody Simon in
Google Scholar
PubMed
Close
,
Nicole A Cipriani Department of Pathology, University of Chicago, Chicago, Illinois, USA

Search for other papers by Nicole A Cipriani in
Google Scholar
PubMed
Close
, and
Tatjana Antic Department of Pathology, University of Chicago, Chicago, Illinois, USA

Search for other papers by Tatjana Antic in
Google Scholar
PubMed
Close

, along with recommended follow-up management based on risk of malignancy ( 1 ). A large majority (65–75%) of thyroid nodules are benign ( 2 ); however, several studies have confirmed a minor yet nonnegligible 1–10% risk of a false-negative cytologic

Open access
Alexander Gorshtein Endocrine Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for other papers by Alexander Gorshtein in
Google Scholar
PubMed
Close
,
Ilana Slutzky-Shraga Endocrine Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for other papers by Ilana Slutzky-Shraga in
Google Scholar
PubMed
Close
,
Eyal Robenshtok Endocrine Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for other papers by Eyal Robenshtok in
Google Scholar
PubMed
Close
,
Carlos Benbassat Endocrine Institute, Shamir Medical Center (Formerly Assaf Harofeh Medical Center), Beer Yaakov, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for other papers by Carlos Benbassat in
Google Scholar
PubMed
Close
, and
Dania Hirsch Endocrine Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for other papers by Dania Hirsch in
Google Scholar
PubMed
Close

. Nodules are divided into 6 diagnostic categories with different implied risk of malignancy (ROM) and clinical management guidelines [ 1 ]. According to the original classification, Bethesda III (B3) nodules have a relatively low (5–15%) ROM and might be

Free access